Berino, Ma Corazon E.
HRN: 23-82-41 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/03/2023
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
10/02/2023
10/08/2023
IV
4.5g LD, Then 2.25g
Q8h
CAP HR
Checking Final Appropriateness
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes